Skip to main content
. 2022 May 14;20:225. doi: 10.1186/s12967-022-03432-5

Fig. 1.

Fig. 1

Flow chart of patient inclusion. Patients sign informed consent prior to the molecular screening. If offered treatment in a cohort, the patients sign a drug specific informed consent before initiating treatment